Anthemis nobilis Linn.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | Chamaemelum nobile (L.) Allioni. |
| Family | Asteraceae. |
| Habitat | The temperate regions of the Himalayas. Wild at several places. |
| English | Roman Chamomile, Double Chamomile. |
| Unani | Gul-e-Baabuuna. |
| Siddha / Tamil | Shimai chamantipu. |
| Action | Mild sedative, anticonvulsant, antispasmodic, antiinflammatory, mild analgesic; used externally for skin disorders, poultice of flowers in sprains and rheumatism. |
| Key Application | Used mainly in France for mild spasmodic gastrointestinal disturbances and sluggishness of bowels, also for nervousness. (PDR.) (German Chamomile has been included by German Commission E among approved herbs, whereas Roman chamomile remains unapproved due to lack of clinical evidence.) The British Herbal Pharmacopoeia recognizes antispasmodic activity of Anthemis nobilis. |
| Taxonomic Cohort | Genus Anthemis (1 documented species); Family Asteraceae (12 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Anthemis nobilis (taxonomically cited with authority Linn.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Asteraceae (primary family classification: Asteraceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy Chamaemelum nobile (L.) Allioni, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: The temperate regions of the Himalayas. Wild at several places.
Across classical and vernacular Indian systems of medicine, Anthemis nobilis is recognized under distinct polyglot nomenclature: in English botanical and trade usage as Roman Chamomile, Double Chamomile; in the Unani-Tibb materia medica (recorded in The National Formulary of Unani Medicine and CCRUM literature) as Gul-e-Baabuuna; in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Shimai chamantipu. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Anthemis nobilis are: Mild sedative, anticonvulsant, antispasmodic, antiinflammatory, mild analgesic; used externally for skin disorders, poultice of flowers in sprains and rheumatism. These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias. Furthermore, international and national regulatory monographs highlight its validated key clinical application: Used mainly in France for mild spasmodic gastrointestinal disturbances and sluggishness of bowels, also for nervousness. (PDR.) (German Chamomile has been included by German Commission E among approved herbs, whereas Roman chamomile remains unapproved due to lack of clinical evidence.) The British Herbal Pharmacopoeia recognizes antispasmodic activity of Anthemis nobilis.
Experimental phytochemistry, active chemical constituents, and pharmacological screening studies reported for Anthemis nobilis establish the following evidence base: The flower heads contain volatile oil (including azulenes and bisabolol); sesquiterpene lactone (nobilin); flavonoids, cyanogenic glycoside, bitter glucoside (anthemic acid); acetylenic salicylic derivatives, coumarins (including scopolin), valerianic acid; tannins. Azulenes and bisabolol are antiinflammatory and antispasmodic, reducing histamine-induced reactions, including hay fever and asthma. Flavonoids, especially anthemidin, are also antispasmodic. Valerianic acid and cyanogenic glycosides are sedative.

Botanical Reference 1: Chamaemelum nobile — Botanical specimen

Botanical Reference 2: Chamaemelum nobile — Botanical specimen

Botanical Reference 3: Anthemis nobilis — Wikimedia Commons reference
4. Comparative Genus & Family Pharmacognosy
Within Indian medicinal flora, Anthemis nobilis stands as a distinct representative of the genus Anthemis. Its therapeutic profile underscores the role of selectively utilized medicinal genera alongside larger polytypic genera.
At the family level, Asteraceae encompasses 12 documented medicinal species (0.66% of the 1,814-species flora). Other representative medicinal members of Asteraceae include: Ageratum conyzoides (Dochunty), Carthamus tinctorius (Kusumbha), Centratherum anthelminticum (Aranya-Jiraka), Gnaphalium luteo-album (Jersey Cudweed), Gynura pseudo-china. In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 12 medicinal species of family Asteraceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Anthemis nobilis follow the plant-part modalities specified under its therapeutic action (Mild sedative, anticonvulsant, antispasmodic, antiinflammatory, mild analgesic; used externally for skin disorders, poultice of flowers in sprains and rheumatism), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Anthemis nobilis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.